Keri Wyllie, MPA

Associate Director, Translational Biology
Codagenix Inc.
Farmingdale, New York, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 1938 - CoviLiv™, a Novel Intranasal Live-Attenuated COVID-19 Vaccine Candidate, Induces Robust Humoral and Cellular Immunity in First-In-Human Clinical Trial CDX-CoV-001

  Friday, October 13, 2023
  2:33 PM – 2:45 PM US ET